News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
Shire Pharmaceuticals Group plc to Ring the NASDAQ Stock Market Opening Bell
March 24, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ADVISORY, March 24, 2008 (PRIME NEWSWIRE) -- What: Angus Russell, CFO and incoming CEO of Shire plc (SHPG), will preside over the opening bell. Today's ringing of the opening bell marks Shire's 10 year anniversary as a NASDAQ listed company.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
FDA
Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls out
August 3, 2026
·
9 min read
·
Jef Akst
Diabetes
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
July 20, 2026
·
7 min read
·
Michael Gibney
Alzheimer’s disease
AAIC 2026: Anti-tau space begins to clarify as Biogen presents detailed data on antisense drug
July 15, 2026
·
6 min read
·
Heather McKenzie
Alzheimer’s disease
AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist
July 10, 2026
·
6 min read
·
Michael Gibney